|
|
Volumn 66, Issue 1, 2005, Pages 80-84
|
|
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIBENZOTHIAZEPINE DERIVATIVE;
FLUPHENAZINE;
LIOTHYRONINE;
NEUROLEPTIC AGENT;
QUETIAPINE;
RISPERIDONE;
THYROTROPIN;
THYROXINE;
ADULT;
ARTICLE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG RESISTANCE;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDY;
PSYCHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
STATISTICS;
THYROID DISEASE;
THYROID FUNCTION TEST;
TREATMENT OUTCOME;
ADULT;
ANTIPSYCHOTIC AGENTS;
DIBENZOTHIAZEPINES;
DOUBLE-BLIND METHOD;
DRUG RESISTANCE;
FEMALE;
FLUPHENAZINE;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RISPERIDONE;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
THYROID DISEASES;
THYROID FUNCTION TESTS;
THYROTROPIN;
THYROXINE;
TREATMENT OUTCOME;
TRIIODOTHYRONINE;
|
|
EID: 13844312732
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v66n0111 Document Type: Article |
|
Times cited : (65)
|
|
References (0)
|
